# Charvi Shetty

> Charvi Shetty is the co-founder and CEO of Aluna, a San Francisco respiratory-health company that makes an FDA-cleared, pocket-sized spirometer paired with games and AI so patients can track lung function from home and send the data to their doctors. A UC Berkeley bioengineer with a UCSF master's in biomedical imaging, she left an algorithm-engineering job at Genentech to build the device, became the youngest recipient of an NSF SBIR grant, and is recognized as one of the youngest female CEOs to bring an FDA-cleared healthtech device to market. In 2023 Aluna raised a $15.3M Series B, bringing total funding to about $27M.

- **Role:** Co-Founder & CEO at Aluna
- **Organizations:** Aluna (formerly Knox Medical Diagnostics), Genentech, UCSF, UC Berkeley
- **Nationality:** American
- **Education:** B.S. in Bioengineering, University of California, Berkeley, M.S. in Biomedical Imaging (thesis), University of California, San Francisco (UCSF)
- **Known for:** Co-founded and leads Aluna, an FDA-cleared at-home respiratory monitoring platform, Youngest recipient of an NSF Small Business Innovation Research (SBIR) grant, Recognized as one of the youngest female CEOs to bring an FDA-cleared healthtech device to market

## Career timeline

- **2010** — Graduate student and laboratory researcher at UCSF, analyzing DTI brain-connectivity data in mTBI patients
- **2012** — Fellow at the Summer Biodesign Immersion Experience, working with the UCSF Pediatric Device Consortium
- **2013** — Earned M.S. in Biomedical Imaging from UCSF; recognized her mission during a Biodesign Capstone project
- **2014** — Co-founded Aluna (originally Knox Medical Diagnostics) and became CEO
- **2020** — Received FDA 510(k) clearance for Aluna's smart spirometer (April 2020)
- **2022** — Aluna patient base grew roughly 10x year over year
- **2023** — Closed a $15.3M Series B led by Matrix Partners, bringing total funding to about $27M

## Achievements

- Co-founded and leads Aluna, an FDA-cleared at-home respiratory monitoring platform
- Youngest recipient of an NSF Small Business Innovation Research (SBIR) grant
- Recognized as one of the youngest female CEOs to bring an FDA-cleared healthtech device to market
- Secured FDA 510(k) clearance for Aluna's spirometer in April 2020
- Raised a $15.3M Series B in 2023 (about $27M total funding)
- Grew Aluna's patient base roughly 10x in 2022

## Latest updates

- **2023-01** — Aluna announced a $15.3M Series B led by Matrix Partners, with Rho Ignition and allergist Dr. Warner Carr participating; Alex Gurevich joined as CFO.

## Links

- Website: https://alunacare.com
- LinkedIn: http://www.linkedin.com/in/charvishetty
- Twitter/X: https://twitter.com/charvishetty
- YouTube: https://www.youtube.com/watch?v=KQZTmDH-zZ4
- Facebook: http://facebook.com/knoxmed

---

Profile page: https://yespress.io/charvi-shetty
Published by YesPress — https://yespress.io
Last updated: 2026-06-14